(Q41676898)

6 October 2017

1 reference

title

Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams (English)

1 reference

6 October 2017

Jacoby GA

1

1 reference

6 October 2017

1 December 1997

1 reference

Infectious Disease Clinics of North America

6 October 2017

1 reference

6 October 2017

11

1 reference

6 October 2017

4

1 reference

6 October 2017

875-887

1 reference

A standard numbering scheme for the class A beta-lactamases

6 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Biochemical characteristics of extended broad spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Genetics of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

More extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Properties of plasmids responsible for production of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Treatment failure due to extended spectrum beta-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Epidemiology of Klebsiella and Hospital-Associated Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

In vivo efficacies of beta-lactam-beta-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970395-0

7 January 2021

10.1016/S0891-5520(05)70395-0

Identifiers

DOI

1 reference

6 October 2017

1 reference

PubMed ID

9421705